Skip to main content
. Author manuscript; available in PMC: 2016 Oct 20.
Published in final edited form as: Mol Psychiatry. 2016 Feb 2;21(11):1608–1612. doi: 10.1038/mp.2015.218

Table1.

Results of Genome-wide Family-based Association Analysis of Imputed Genotypes using Three Large Collections of Multiplex AD Study Families.

Panel A: Functional variants; SNPs that are either in a gene or in LD with the gene.
SNP Chr Position Fams
(MA)
Zscore
(MA)
P-value
(MA)
Effect Direction
(MA)
Gene NIMH NCRAD NIA Approach
rs7609954 3 61636156 696 5.492 3.98E-08 ++++++ PTPRG 8.73E-03 7.57E-03 1.73E-03 2
rs1347297 2 179244986 640 5.469 4.53E-08 +++ OSBPL6 3.65E-02 5.85E-02 1.24E-06 1
rs11749176 5 44145931 840 5.218 1.81E-07 ++++++ FGF10 5.95E-02 3.74E-02 3.12E-02 2
rs12378800 9 100631820 438 5.218 1.81E-07 ++++++ FOXE1 6.33E-02 1.92E-02 1.05E-01 2
rs185968827 6 56708510 844 5.158 2.49E-07 ++++++ DST 1.12E-02 4.09E-02 5.25E-02 2
rs62400067 6 20592984 502 5.092 3.54E-07 ++++++ CDKAL1 2.51E-02 6.81E-02 1.65E-04 2
rs9304861 19 35271888 622 5.082 3.74E-07 ++++++ ZNF599 2.19E-02 5.92E-03 3.97E-02 2
rs9994441 4 170094562 622 4.99 6.05E-07 ++++++ SH3RF1 5.92E-01 1.52E-02 1.11E-01 2
rs3931397 4 149079497 524 4.984 6.22E-07 ++++++ NR3C2 1.62E-02 1.85E-02 2.73E-01 2
rs72953347 2 179274829 670 4.98 6.36E-07 +++ OSBPL6 3.27E-02 2.72E-01 3.39E-06 2
rs115500410 5 76852235 922 4.963 6.94E-07 ++++++ WDR41 1.85E-01 1.88E-01 3.06E-04 2
rs56146971 14 91920101 904 4.941 7.76E-07 ++++++ SMEK1 7.24E-03 5.18E-02 7.94E-03 2
rs77220498 9 100700832 440 4.946 7.59E-07 ++++++ HEMGN 2.16E-01 1.31E-02 1.15E-01 2
rs6491411 13 98904568 872 4.911 9.08E-07 ++++++ FARP1 1.91E-01 2.04E-02 1.36E-04 2
rs10456232 6 20579123 258 4.9 9.60E-07 +++ CDKAL1 2.73E-02 2.75E-02 1.49E-04 1
Panel B: Intergenic variants; genes close to the associated markers are listed with proximal distance in base-pairs.
SNP Chr Position Fams
(MA)
Zscore
(MA)
P-value
(MA)
Effect Direction
(MA)
Gene (proximity) NIMH NCRAD NIA Approach
rs1513625 2 101314473 992 5.479 4.28E-08 ++++++ PDCL3 (+121276) 7.64E-03 1.12E-02 3.85E-01 2
rs543844 6 44424800 968 5.323 1.02E-07 ++++++ CDC5L (+6637) 3.50E-03 2.07E-01 2.63E-02 2
rs186971130 2 104619458 576 5.311 1.09E-07 ++++++ - 1.36E-03 8.69E-01 1.64E-02 2
rs7374058 3 26246575 794 5.137 2.80E-07 ++++++ LINC00692 (331384) 5.00E-02 2.07E-02 4.40E-02 2
rs73310256 10 92438849 478 5.123 3.01E-07 ++++++ HTR7 (−61729) 8.15E-02 1.25E-01 5.58E-02 2
rs6908580 6 92577371 1058 5.099 3.41E-07 ++++++ - 5.79E-03 2.25E-01 3.30E-02 2
rs7047415 9 98541232 578 5.096 3.48E-07 ++++++ DKFZP434H0512 (+4219) 3.73E-02 4.36E-01 3.33E-04 2
rs982100 2 118475544 740 5.08 3.77E-07 ++++++ DDX18 (−96682) 3.02E-02 5.88E-01 7.66E-03 2
rs75718659 4 187743086 460 5.052 4.37E-07 ++++++ FAT1 (+95210) 2.12E-02 7.51E-01 5.57E-01 2
rs140633572 6 107279935 408 5.03 4.92E-07 ++++++ C6orf203 (−69472) 1.66E-03 6.68E-01 3.68E-01 2
rs1443024 2 185376297 976 4.999 5.78E-07 ++++++ ZNF804A (−86796) 6.57E-02 4.66E-02 5.23E-03 2
rs11773349 7 64407164 562 4.991 6.01E-07 ++++++ ZNF273 (+15820) 4.69E-02 8.52E-01 1.73E-03 2
rs36060340 1 233622928 766 4.975 6.54E-07 ++++++ MLK4 (+102034) 1.05E-03 2.89E-01 1.88E-01 2
rs1774093 9 104647156 766 4.956 7.19E-07 ++++++ GRIN3A (+146294) 4.96E-03 6.29E-01 3.81E-01 2
rs857551 21 44829992 588 4.949 7.45E-07 ++++++ SIK1 (−4403) 3.89E-03 5.87E-01 1.15E-01 2
rs9546312 13 83746951 658 4.92 8.68E-07 ++++++ - 6.91E-02 1.16E-01 2.61E-01 2
rs4705644 5 113577164 862 4.905 9.33E-07 ++++++ KCNN2 (−119478) 2.85E-05 6.82E-01 2.48E-01 2

Legend to Table 1: FBAT-GEE method was used in the analyses using affection status and age at onset as a multivariate phenotype. The p values are nominal and two-tailed for all the associated markers. Fams indicates the number of informative families contributing to the test statistic. Age of onset coding based on Wilcoxon statistic. Meta-analysis results including the imputed data sets NIMH, NIA and NCRAD. Zscore, Z-score of the test statistic (negative scores indicate under-transmission of minor allele to affected individuals). P-value = P-value derived from the meta-analysis. Thresholds to achieve genome-wide significance is 5·10−08. Effect Direction (NCRAD, NIA, NIMH), the effect direction is positive if the involved studies have the same direction compared to the first study, otherwise it's negative. The FBAT-GEE p-values of the association signal from the three individual family cohort are listed in the columns, NIMH, NCRAD and NIA. These p-values were used in meta-analysis as described in the methods. Approach indicates the kind of analysis (1) FBAT GEE Within-Family and (2) FBAT GEE Between-Family as described in the material and method section.